1. Prevalence of and Risk Factors for Drug-Related Readmissions in Older Adults: A Systematic Review and Meta-Analysis

   • Narisha Prasad
   • Edward C. Y. Lau
   • Edwin C. K. Tan

   Systematic Review Open access 21 October 2023 Pages: 1 - 11

   

2. Potentially inappropriate prescribing in multimorbid and polymedicated older adults with AF: A Systematic Review and Meta-Analysis

   • Cheima Amrouch
   • Delphine Vauterin
   • the AFFIRMO consortium

   Systematic Review Open access 17 November 2023 Pages: 13 - 30

   

3. Cutaneous Lupus Erythematosus: Review and Considerations for Older Populations

   • Briana Heinly
   • Astia Allenzara
   • Galen T. Foulke

   Review Article 22 November 2023 Pages: 31 - 43

   

4. Evaluating the Safety of an Educational Deprescribing Intervention: Lessons from the Optimize Trial

   • Cynthia M. Boyd
   • Susan M. Shetterly
   • Elizabeth A. Bayliss

   Original Research Article 20 November 2023 Pages: 45 - 54

   

5. Prevalence and factors associated with inappropriate dosing of apixaban and rivaroxaban in hospitalized older adults with atrial fibrillation: a cross-sectional study

   • Théodore Decaix
   • Kenza Kemache
   • Éric Pautas

   Original Research Article 13 November 2023 Pages: 55 - 64

   

6. Do Proton Pump Inhibitors Reduce Upper Gastrointestinal Bleeding in Older Patients with Atrial Fibrillation Treated with Oral Anticoagulants? A Nationwide Cohort Study in France

   • Solene Drusch
   • Anke Neumann
   • Marie Herr

   Original Research Article Open access 20 December 2023 Pages: 65 - 76

   

7. Comment on: “Patient Perceptions of Opioids and Benzodiazepines and Attitudes Toward Deprescribing”

   • Aili V. Langford
   • Carl R. Schneider
   • Danijela Gnjidic

   Letter to the Editor 02 January 2024 Pages: 77 - 78

8. Authors’ Reply to Langford et al.: “Patient Perceptions of Opioids and Benzodiazepines and Attitudes Toward Deprescribing”

   • Casey J. Kelley
   • Joshua Niznik
   • Ellen Roberts

   Letter to the Editor 02 January 2024 Pages: 79 - 80

9. Correction to: Prevalence and factors associated with inappropriate dosing of apixaban and rivaroxaban in hospitalized older adults with atrial fibrillation: a cross‑sectional study

   • Théodore Decaix
   • Kenza Kemache
   • Éric Pautas

   Correction 21 December 2023 Pages: 81 - 81